2018
DOI: 10.4103/ijd.ijd_458_17
|View full text |Cite
|
Sign up to set email alerts
|

Cyclosporine in generalized bullous-fixed drug eruption

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 6 publications
0
10
0
Order By: Relevance
“…In this case, cyclosporine was initiated due to the patient's rapidly progressive blistering, severe pain, and extensive body surface area involvement (28%). Cyclosporine was chosen over continuing the prednisone as multiple GBFDE studies have shown that cyclosporine results in rapid cessation of blistering, re-epithelialization of skin, and resolution of lesions with minimal changes in pigmentation [ 11 , 12 , 14 , 22 ]. Due to its minimal side effects when used acutely and the direct mechanism of inhibiting T-cell activation, it has been suggested to be a therapeutic agent for treating FDE superior to prednisone and intravenous immunoglobulin [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this case, cyclosporine was initiated due to the patient's rapidly progressive blistering, severe pain, and extensive body surface area involvement (28%). Cyclosporine was chosen over continuing the prednisone as multiple GBFDE studies have shown that cyclosporine results in rapid cessation of blistering, re-epithelialization of skin, and resolution of lesions with minimal changes in pigmentation [ 11 , 12 , 14 , 22 ]. Due to its minimal side effects when used acutely and the direct mechanism of inhibiting T-cell activation, it has been suggested to be a therapeutic agent for treating FDE superior to prednisone and intravenous immunoglobulin [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…A further literature search identified 5 adult cases of GBFDE treated with cyclosporine, but no paediatric cases (Table 1 ) [ 11 , 12 , 13 , 14 ]. Variable dosages (100 mg/day, 2 mg/kg/day, or 5 mg/kg/day), routes of administration (oral or intravenous), and durations (5–7 days) were used, reflecting both the heterogeneity of institutional and practitioner preferences and the lack of evidence for use in GBFDE.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The usefulness of granulysin to distinguish both entities has been described, since serum and tissue levels are lower in GBFDE. 1,4 Cyclosporine acts by inhibiting the dephosphorylation of the nuclear factor of activated T cells, generating a reduction of IL-2 and thus an inhibition of the response of CD4+ and CD8+ lymphocytes. These latter are the principal mediators of FDE.…”
mentioning
confidence: 99%
“…5 Thus, cyclosporine is an excellent therapeutic option for this rare and lethal variant but it has scarcely been reported in the literature. 4,5 Future studies are…”
mentioning
confidence: 99%